
- 积分
- 299
- 威望
- 299
- 包包
- 1702
|

是不是这篇啊??有人发过了~~~0 h2 A) W2 h. f9 q9 Q8 x
5 N% B1 s7 z) h e% `
诱导的多能干细胞(iPSCs)为艾滋病的治疗提供了希望
+ P$ Z0 E% ~* Chttp://www.stemcell8.cn/thread-36638-1-1.html6 r# W. h6 n8 j8 r' b3 x
7 t1 V _$ Q3 i4 I4 t
4 \, W9 f. X) X' |. }6 oMol Ther. 2011 Mar;19(3):584-93. Epub 2010 Nov 30.. _/ a0 L2 d2 e
l) e" s* c5 S6 k$ ^Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell-derived Induced Pluripotent Stem Cells.! N0 q/ h; q& y) S* c3 I/ R
Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS.
& _7 f* o$ z) j# `* L- [" z; `8 [
! \- Q4 W- Q u, M# tStem Cell Program, Department of Internal Medicine, University of California, Davis, Sacramento, California, USA.
/ s1 j1 W( Y2 Q4 j) L
: P* j" E) H. o, X' X5 x" NAbstract
9 o& p' W, v s% a, b; UInduced pluripotent stem cells (iPSCs) have radically advanced the field of regenerative medicine by making possible the production of patient-specific pluripotent stem cells from adult individuals. By developing iPSCs to treat HIV, there is the potential for generating a continuous supply of therapeutic cells for transplantation into HIV-infected patients. In this study, we have used human hematopoietic stem cells (HSCs) to generate anti-HIV gene expressing iPSCs for HIV gene therapy. HSCs were dedifferentiated into continuously growing iPSC lines with four reprogramming factors and a combination anti-HIV lentiviral vector containing a CCR5 short hairpin RNA (shRNA) and a human/rhesus chimeric TRIM5α gene. Upon directed differentiation of the anti-HIV iPSCs toward the hematopoietic lineage, a robust quantity of colony-forming CD133(+) HSCs were obtained. These cells were further differentiated into functional end-stage macrophages which displayed a normal phenotypic profile. Upon viral challenge, the anti-HIV iPSC-derived macrophages exhibited strong protection from HIV-1 infection. Here, we demonstrate the ability of iPSCs to develop into HIV-1 resistant immune cells and highlight the potential use of iPSCs for HIV gene and cellular therapies.
0 @4 r, U$ Y4 k0 N) Y" \: x7 O2 J
|
|